PRIP Component B - Industry, Startup and MSME Pharma-MedTech R&D Projects

What it is

Accelerate discovery, development, validation and commercialization of innovative medicines, medical devices and related technologies while strengthening industry-academia collaboration.

What you get

• PRIP Pharma-MedTech R&D project assistance

Who it is for

• the project fits a PRIP priority area: new medicines, complex generics/biosimilars, precision medicine, medical devices, orphan drugs or antimicrobial resistance
• the applicant and project satisfy the current early-stage or later-stage TRL route
• the applicant can meet co-funding and financial-closure conditions where applicable
• the proposal has milestones within the scheme period even if the longer R&D journey extends beyond it
• the application is submitted through the official PRIP portal and any academic collaboration is documented

How to apply

1. 1
   Select the priority area and TRL route

   Choose an eligible Pharma/MedTech priority area and determine whether the project is early-stage or later-stage under the current FAQ and guidelines.

   Official step
2. 2
   Prepare technical and evidence dossier

   Document product/technology, TRL, novelty, regulatory path, IP/data, team, milestones, academic partner and commercialization plan.

   Official step
3. 3
   Build the co-funding plan

   Prepare your share of the project cost and documentary evidence of financial closure; the assistance cap is not the total project budget.

   Official step
4. 4
   Submit through the official portal

   Use the PRIP portal and current call; early-stage applicants should be ready for the two-step concept-note and detailed-application process described on the portal.

   Official step

Keep ready